20th Annual European Congress

Saturday, 4 November 2017 – Full Day
Introduction to Health Economic/Pharmacoeconomic Evaluations
Saturday, 4 November 2017 – Morning Session
Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources
Introduction to Patient-Reported Outcomes Assessment
Introduction to Modeling
Development of Conceptual Models
Cost-Effectiveness Analysis Alongside Clinical Trials
Elements of Pharmaceutical / Biotech Pricing
Conjoint Analysis – Theory & Methods

Saturday, 4 November 2017 – Afternoon Session
Introduction to Health Technology Assessment
Meta-Analysis & Systematic Literature Review
Statistical Methods for Pharmacoeconomics & Outcomes Research
Use of Propensity Scores in Observational Studies of Treatment Effects
Collecting Health-State Utility Estimates for Economic Models in Clinical Studies
Pharmacoeconomic Modeling – Applications
NEW! Introduction to Designing Authentic and Impactful Patient-Centered Outcomes Research

Sunday, 5 November 2017 – Full Day
Bayesian Analysis – Overview and Applications

Sunday, 5 November 2017 – Morning Session
NEW! US Payers – an Introduction to Their Structures, Evidence Needs, and Decision-Making Process
Using DICE Simulation for Health Economic Analyses
Use of Instrumental Variables in Observational Studies of Treatment Effects
Transferability and Relevance of Cost-Effectiveness Data Between Countries
NEW! Mapping to Estimate Utility Values from Non-Preference Based Outcome Measures
Budget Impact Analysis I: A 6-Step Approach
Risk-Sharing / Performance-Based Arrangements for Drugs and Other Medical Products
Understanding Survival Modeling with Application to HTA

Sunday, 5 November 2017 – Afternoon Session
Budget Impact Analysis II: Applications & Design Issues
Advanced Methods for Addressing Selection Bias in Real-World Effectiveness and Cost-Effectiveness Studies
Introduction to the Economic Analysis of Diagnostics
Network Meta-Analysis in Relative Effectiveness Research
Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of Managed Entry Agreements
Adjusting for Time-Dependent Confounding and Treatment Switching Bias in Observational Studies and Clinical Trials: Purpose, Methods, Good Practices and Acceptance in HTA
Reimbursement Systems for Pharmaceuticals in Europe
Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is: